| | Title | Author(s) | Year | View Count | | 1 |  | Indolent T-cell large granular lymphocyte leukaemia after haematopoietic SCT: A clinicopathologic and molecular analysis | Gill, H; Ip, AHW; Leung, R; So, JCC; Pang, AWK; Tse, E; Leung, AYH; Lie, AKW; Kwong, YL | 2012 | 130 |
| 2 | | Type II enteropathy-associated T-cell lymphoma: a multicenter analysis from the Asia Lymphoma Study Group | Tse, E; Gill, H; Loong, F; Kim, SJ; NG, SB; Tang, T; Ko, YH; Chng, WJ; Lim, ST; Kim, WS; Kwong, YL | 2012 | 122 |
| 3 | | Donor cell leukaemia after allogeneic haematopoietic SCT followed by prolonged thalidomide maintenance for multiple myeloma | Chan, TSY; Au, WY; Lam, K; Lam, YF; So, CC; Leung, AYH; Tse, E; Lie, AKW; Kwong, YL | 2012 | 327 |
| 4 | | Practical management of natural killer/T-cell lymphoma | Tse, E; Kwong, YL | 2012 | 57 |
| 5 |  | Treatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach, PAD or VTD | Chim, JCS; Lie, AKW; Chan, YET; Liu, HSY; Lau, CW; Yip, SY; Sim, J; Wan, TSK; Ma, ESK; Liang, RHS; Tse, EWC; Kwong, YL | 2012 | 71 |
| 6 | | The CDK Subunit CKS2 Counteracts CKS1 to Control Cyclin A/CDK2 Activity in Maintaining Replicative Fidelity and Neurodevelopment | Frontini, M; Kukalev, A; Leo, E; Ng, YM; Cervantes, M; Cheng, CW; Holic,; Dormann,; Tse, EWC; Pommier, Y; Yu, CCPV | 2012 | 62 |
| 7 | | SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group | Kwong, YL; Kim, WS; Lim, ST; Kim, SJ; Tang, T; Tse, EWC; Leung, AYH; Chim, JCS | 2012 | 74 |
| 8 | | Post-transplant lymphoproliferative diseases in Asian solid organ transplant recipients: Late onset and favorable response to treatment | Chan, TS; Hwang, YY; Gill, H; Au, WY; Leung, AY; Tse, E; Chim, CS; Loong, F; Kwong, YL | 2012 | 73 |
| 9 |  | Non-gastric marginal zone B cell lymphoma: Clinicopathologic features and treatment results | Gill, H; Chim, CS; Au, WY; Loong, F; Tse, E; Leung, AYH; Kwong, YL | 2011 | 860 |
| 10 | | Effects of Azithromycin in bronchiolitis obliterans syndrome after hematopoietic SCTa randomized double-blinded placebo-controlled study | Lam, DCL; Lam, B; Wong, MKY; Lu, C; Au, WY; Tse, EWC; Leung, AYH; Kwong, YL; Liang, RHS; Lam, WK; Ip, MSM; Lie, AKW | 2011 | 888 |
| 11 | | T-cell prolymphocytic leukaemia: Spontaneous immunophenotypical switch from CD4 to CD8 expression | Tse, E; So, CC; Cheung, WWW; Kwong, YL | 2011 | 98 |
| 12 | | Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia | Tse, E; Leung, AYH; Sim, J; Lee, HKK; Liu, HSY; Yip, SF; Kwong, YL | 2011 | 119 |
| 13 | | Primary immune thrombocytopenia responding to antithyroid treatment in a patient with Graves' disease | Gill, H; Hwang, YY; Tse, E | 2011 | 87 |
| 14 | | Synchronous Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly and Epstein-Barr virus-positive classical Hodgkin lymphoma | Hwang, YY; Leung, AYH; Lau, WH; Loong, F; So, JCC; Tse, E; Kwong, YL | 2011 | 79 |
| 15 | | Treatment algorithms for mature T-cell and natural killer-cell neoplasms | Tse, E; Kwong, YL | 2011 | 59 |
| 16 | | Management of chronic lymphocytic leukaemia | Tse, E; Singh Gill, H | 2011 | 60 |
| 17 | | Extranodal natural-killer/T-cell lymphoma, nasal type | Gill, H; Liang, RHS; Tse, E | 2010 | 73 |
| 18 | | T-cell large granular lymphocyte leukemia: An Asian perspective | Kwong, YL; Au, WY; Leung, AYH; Tse, EWC | 2010 | 538 |
| 19 | | Rivaroxaban: an oral factor Xa inhibitor in the management of thrombotic diseases | Kwong, YL; Tse, EWC | 2010 | 408 |
| 20 | | Absence of NPM1 promoter hypermethylation in human myelodysplastic syndrome | Cheng, YY; Chau, D; Chan, T; Gill, H; Liang, R; Kwong, YL; Tse, E | 2010 | 59 |
|
